Zimmer Biomet Holdings (ZBH): Accelerating Growth To Market Rates - Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
UBS Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q Earnings Report
August 2, 2016 9:18 AM EDTUBS reiterated a Neutral rating on Zimmer Biomet (NYSE: ZBH), and raised the price target to $132.00 (from $117.00), following the company's 2Q earnings report.
Analyst Matt Miksic commented, "WW sales growth improved in Q2 for most business lines, partially driven by extra selling days (+1.9% WW), and Zimmer Biomet narrowed its gap in... More
